Chiangrai Prachanukroh Hospital is the main hospital of Chiang Rai Province, Thailand, and is classified under the Ministry of Public Health as a regional hospital. It has a CPIRD Medical Education Center which trains doctors of the Faculty of Medicine, Chiang Mai University.

During the past decade, Chiangrai Prachanukroh Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 12 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chiangrai Prachanukroh Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials, followed by "Institut de Recherche pour le Developpement" with 8 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "University of Oxford" with 3 trials sponsored and "PENTA Foundation" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chiangrai Prachanukroh Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "Chiangrai Prachanukroh Hospital" with 4 trials as a collaborator, "Ministry of Health, Thailand" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator and "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Chiangrai Prachanukroh Hospital" are "HIV Infections" (13 trials), "HIV Infection" (5 trials), "HIV" (3 trials), "Pregnancy" (3 trials) and "Scrub Typhus" (3 trials). Many other conditions were trialed in "Chiangrai Prachanukroh Hospital" in a lesser frequency.

Most popular intervention types in "Chiangrai Prachanukroh Hospital" are "Drug" (30 trials), "Dietary Supplement" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials) and "Dolutegravir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chiangrai Prachanukroh Hospital" are 27 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Chiangrai Prachanukroh Hospital". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Chiangrai Prachanukroh Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chiangrai Prachanukroh Hospital, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".